Introduction:
Idiopathic forms of interstitial lung disease (ILD) in children are associated with a wide spectrum of underlying pathologies. Until recently, a single classification system has been used, regardless of age, and children with ILD were forced into published adult disease classification systems 1 . In 2007, a multi-disciplinary working group of pediatric pathologists, clinicians and radiologist (the Children's Interstitial Lung Disease (chILD) Research
Cooperative) designed and conducted a retrospective clinical, radiographic and histopathologic review and proposed a new classification system for children with diffuse lung disease (chILD syndrome) 2 . In this classification, surfactant genetic abnormalities account for more than 10 % of the patients reviewed. Pulmonary surfactant is a mixture of phospholipids and specific proteins secreted by type II epithelial cell to reduce the alveolar surface tension at the air-liquid interface and prevent end-expiratory atelectasis 3 . The hydrophobic surfactant protein SP-C, play an important role in the spreading and stabilization of phospholipids films in the alveolus 3 highlighted by lung disease caused by inherited abnormalities in its genes 4, 5 . Since the first description by Nogee et al., more than 35 dominantly expressed mutations in the SFTPC gene have been identified in association with acute or chronic lung disease in patients ranging in age from newborn to adults [6] [7] [8] [9] [10] . These mutations, whether inherited or spontaneous are always found in an autosomal dominant form, the most frequently observed (nearly 50 %) being p. Although consensus exists on the need to consider early open lung in children with ILD, genetic testing for SFTPC mutation has become widespread and may be performed relatively quickly. In addition, recent advances in imaging techniques have contributed to more efficiently predict histological findings. Indeed, HRCT has been proposed for either diagnosis or following ILD precluding the need to obtain a surgical biopsy 13, 14 . Thus, the aim of the present study was to determine HRCT features of children with SFTPC mutation and to bring new insight in the correlation between HRCT and histological findings. To address these questions HRCT finding of a cohort of 15 children with interstitial chronic lung disease related to SFTPC gene mutations were retrospectively reviewed and subsequently correlated with histological analysis when lung biopsies were available. 
Patients and Methods
This study is a retrospective study performed in 2 university hospital-based pediatric pulmonology practice (Hôpital Armand Trousseau and Hôpital Necker enfants-malades, Paris, France) for a 15-year period (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) . The protocol was accepted by the Committee for the protection of individuals in Biochemical research as required by French legislation and written informed consent was obtained from the patients or their next of kin included in this study.
Patients
The characteristics of patients are summarized in Table 1 . Fifteen children, 7 females and 8 males with a definitive diagnosis of SFTPC gene mutation were included. All the patients were immunocompetent and screening for metabolic, infectious, and immunological etiologies was negative. Genetic and clinical characteristics of all these patients have been described in detail in previous reports 8, 15 . Three patients, members, or relatives of a same family, have also been reported previously 6 . Median age of onset was 2 (range 0-18) months.
Three patients had neonatal respiratory distress, and symptom onset was associated with acute bronchiolitis in 7 (47 %) patients. Cough, tachypnea, and gastroesophageal reflux and failure to thrive were initially noticed in all the children. Physical examination at presentation revealed tachypnea and retraction in all patients. Low oxygen saturation (<95%) was observed initially in all patients. Treatment are summarized in table 1 and included methylprednisolone pulse (n=15), hydroxychloroquin (n=8) and azithromycin (n=5). Median follow-up was 3.1
(1-17.3) years. At the end of the study, all the children were alive but 11 patients (73 %) were still symptomatic with cough, dyspnea or exercise intolerance. was assessed. Ground-glass opacities describe lung that is higher in attenuation than a normal lung on inspiration but lower than the attenuation of bronchial walls and blood vessels so that these lung markings remain visible 16 . The term lung cyst is used to refer to a well-defined, rounded, and circumscribed lesion, with a wall that may be uniform or varied in thickness but which is usually thin (with thickness of less than 3 mm) 17 . Because this study was retrospective, the intervals of follow-up HRCT scanners were highly centre-dependent and based on the decision of the physician in charge of the child. Only HRCT scanners available ware taking into consideration for analysis. Control HRCT scans were obtained from 6 agematched patients with a definitive diagnosis of ABCA3 (ATP-binding cassette subfamily A, member 3) mutations, a gene expressed in lamellar bodies of alveolar type II cells which has a critical role in surfactant storage and homeostasis 18 . Among them, 2 patients carried homozygous missense mutations, 3 patients carried compound heterozygous missense mutations and 1 child had compound heterozygous missense and nonsense mutations.
Median age at HRCT scans was 2 months (range 1 month to 12 years).
Lung biopsies and their analysis
Surgical lung biopsies ranging from 0.5 to 1cm were obtained from different lobes in 8 children at the age of 3 to 7 months (mean age, 4 months) before treatment onset. Biopsy sites are summarized in Table 1 . Specimens were further fixed in formalin and embedded in paraffin. A five-micrometer tissue section was stained with H and E stain (hematoxylin and eosin stain). Slides were examined by 2 pathologists. Radiology-pathology correlation was performed in 8 cases. All 8 children had only 1 open lung biopsy.
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Results:
Initial HRCT findings
The median age at initial HRCT scanner was 4 (range 1-40) months (one child had the scanner performed 40 months after the diagnosis for technical reasons). High-resolution CT findings are summarized in Table 2 . The most frequent abnormalities identified on initial HRCT were ground-glass opacities (93 %) and lung cysts (40 %). Other abnormalities noted included interlobular septal thickening (7 %), air space consolidation (7 %), paraseptal emphysema (13 %), and pulmonary nodules (7 %). In comparison, ground-glass opacities were constantly observed in all of the 6 patients with ABCA3 mutations. However, opacities were more prominent with presence in some cases of alveolar condensations.
Bilateral ground-glass opacities were shown in 14 children (Table 3) , either as an isolated finding (60 %) or as part of a mixed pattern with lung cysts (33 %), air space consolidation (7 %), paraseptal emphysema, and centrolobular nodules (7 %). They were homogeneously diffuse in 9 cases (60 %) ( Figure 1A ). When a patchy distribution was present, this was noted to have basal subpleural predominance in 1 case (7 %), predominance for the lower lobes in 2 cases (13 %) ( Figure 1B ), a central predominance in 1 case (7 %), and a predominance for the posterior portions of the lung in 1 case (7 %).
Thin-walled (<1mm) lung cysts of varying sizes were seen in 6 infants (40 %) (Table 4) , either as an isolated finding (7 %) (Figure 2A ), or as a mixed pattern with areas of groundglass opacities (33 %), paraseptal emphysema (13 %) ( Figure 2B ), septal thickening (7 %), and non-septal thickening (7 %). A predominantly subpleural distribution was seen in 1 child (7 %); diffuse cysts with random distribution was seen in 4 cases (27 %) and upper lung zone predominance was seen in 1 case (7 %). Figure 5A ). These lesions were diffuse in 7 cases (90 Figure 6A ). There was no interstitial pulmonary fibrosis or alveolar proteinosis observed.
Follow-up HRCT scan
Relation between HRCT and pathology findings
Radiological-pathological confrontation is summarized in Table 6 . Ground-glass opacities on
HRCT were observed in all the patients except 1 in which the CT scan was performed late (40 months). All these children also have diffuse alveolar septal thickening by primitive mesenchymal cells and lymphocytes, intra-alveolar accumulation of macrophages, and type II pneumocyte hyperplasia. Small lung cysts were observed initially in half of the children but appeared during follow-up in all the cases. They were related with dilatation of the terminal bronchioles and alveolar duct which were noticed in all but one biopsy.
Discussion:
In the present study, we have shown for the first time in a large cohort of children with SFTPC mutation associated lung diseases that HRCT pattern were characterized with 2 main abnormalities: ground-glass opacities that were predominately diffuse but can be patchy in some cases and lung cysts with thin wall and different sizes.
Ground-glass opacities have been commonly described in previous reports 6, 19, 20 . They are predominately diffuse but can be patchy in some cases. In our series, they were present in all the patients except one in whom the HRCT scan was done late. We also note in our study the high frequency of cystic lesions on HRCT scan. They appeared in 45% of the children during follow-up and increased in number in 45%. Similar change during follow-up is typical of surfactant abnormality and was noted by Brody 16 . In our series, ground-glass attenuation This HRCT presentation, namely the ground-glass opacities and cystic patterns is, nonetheless, not specific of SFTPC associated disorders. We have shown that this presentation may also be observed in children with ABCA3 mutations as previously described 21 .However, the high frequency of SFTPC associated disorders in children ILD 2, 7 , the feasibility of SFTPC genetic analysis as well as the difficulty to perform lung biopsy in patients with fragile respiratory condition strongly encourage to perform SFTPC genetic screening before lung biopsy in children with ground-glass opacities associated with cystic lung changes on HRCT scanner.
In number of macrophages in the alveolar lumen 25 and as NSIP and UIP because of the numerous inflammatory cells in the alveolar septum 26, 27 . In this study, we have related ground-glass opacities on HRCT to diffuse alveolar septal thickening by primitive millimetric small cysts corresponding to a dilatation of respiratory bronchioli and alveolar ducts, sometimes in subpleural area and periseptal regions, were observed, whereas histological emphysema was not present. Large cyst (>1mm) probably corresponds to emphysema, whereas small cyst may be in part due to cystic dilatation of the proximal part of the acini.
After natural exposure, CT scan is the greatest contributor to total radiation exposure and
Brenner et al. notes that the evidence is "convincing" that the radiation dose from CT scans can lead to cancer induction in adults and "very convincing" in the case of children 28 . Hence, it is of importance to adjust protocols in order to reduce unnecessary radiation exposure from CT. Exposure parameters have considerably decreased during the study, but these efforts must be sustained. In this context, we also recommend to use a sequential technique during followup, including for multi detector CT.
With this report as our basis, the presence of bilateral ground-glass opacity or a combination of ground-glass opacities and cysts suggests the diagnosis of SFTPC mutation associated disorders and strongly encourage to perform genetic screening. We believe that this study is of value in highlighting this rare condition, and future prospective studies in children and adults are needed to further characterize CT findings in surfactant dysfunction disorders.
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Abstract:
Aim of the study Determine high-resolution tomography (HRCT) scan characteristics in children with SFTPC mutation and correlate them to histological findings.
Patients and Methods
This retrospective multicenter study included 15 children (7 females and 8 males) with SFTPC mutations. HRCT scans have been performed in all the children and lung biopsies in 8 children.
Results
From all signs assessed on initial HRCT scans, ground-glass opacities (n=14, 93 %) and lung cysts (n=6, 40 %) were predominant. Interlobular septal thickening (n=1, 7 %), air space consolidation (n=1, 7 %), paraseptal emphysema (n=2, 13 %), and pulmonary nodules (n=1, 7 %) were also found. Histological analysis revealed accumulation of macrophages in the alveolar lumen, type II pneumocyte hyperplasia, and alveolar septal thickening. Dilatation of the respiratory bronchiole and alveolar duct associated with muscular hyperplasia were also described. Interestingly, lung cysts on HRCT scans were associated with dilatation of terminal bronchioli and alveolar duct in lung biopsies.
Conclusion
In children with SFTPC mutations, HRCT scan finding were highly correlated to the histological findings and, as such, represent a useful tool to identify patients that may require SFTPC gene sequencing. Although consensus exists on the need to consider early open lung in children with ILD, genetic testing for SFTPC mutation has become widespread and may be performed relatively quickly. In addition, recent advances in imaging techniques have contributed to more efficiently predict histological findings. Indeed, HRCT has been proposed for either diagnosis or following ILD precluding the need to obtain a surgical biopsy 13, 14 . Thus, the aim of the present study was to determine HRCT features of children with SFTPC mutation and to bring new insight in the correlation between HRCT and histological findings. To address these questions HRCT finding of a cohort of 15 children with interstitial chronic lung disease related to SFTPC gene mutations were retrospectively reviewed and subsequently correlated with histological analysis when lung biopsies were available. 
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(1-17.3) years. At the end of the study, all the children were alive but 11 patients (73 %) were still symptomatic with cough, dyspnea or exercise intolerance. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 was assessed. Ground-glass opacities describe lung that is higher in attenuation than a normal lung on inspiration but lower than the attenuation of bronchial walls and blood vessels so that these lung markings remain visible 16 . The term lung cyst is used to refer to a well-defined, rounded, and circumscribed lesion, with a wall that may be uniform or varied in thickness but which is usually thin (with thickness of less than 3 mm) 17 . Because this study was retrospective, the intervals of follow-up HRCT scanners were highly centre-dependent and Median age at HRCT scans was 2 months (range 1 month to 12 years).
Lung biopsies and their analysis
Surgical lung biopsies ranging from 0.5 to 1cm were obtained from different lobes in 8 children at the age of 3 to 7 months (mean age, 4 months) before treatment onset. Biopsy sites are summarized in Table 1 
Results:
The median age at initial HRCT scanner was 4 (range 1-40) months (one child had the scanner performed 40 months after the diagnosis for technical reasons). High-resolution CT findings are summarized in Table 2 . The most frequent abnormalities identified on initial HRCT were ground-glass opacities (93 %) and lung cysts (40 %). Other abnormalities noted included interlobular septal thickening (7 %), air space consolidation (7 %), paraseptal emphysema (13 %), and pulmonary nodules (7 %). In comparison, ground-glass opacities
were constantly observed in all of the 6 patients with ABCA3 mutations. However, opacities were more prominent with presence in some cases of alveolar condensations.
Bilateral ground-glass opacities were shown in 14 children (Table 3) , either as an isolated finding (60 %) or as part of a mixed pattern with lung cysts (33 %), air space consolidation (7 %), paraseptal emphysema, and centrolobular nodules (7 %). They were homogeneously diffuse in 9 cases (60 %) ( Figure 1A ). When a patchy distribution was present, this was noted to have basal subpleural predominance in 1 case (7 %), predominance for the lower lobes in 2 cases (13 %) ( Figure 1B) , a central predominance in 1 case (7 %), and a predominance for the posterior portions of the lung in 1 case (7 %).
Thin-walled (<1mm) lung cysts of varying sizes were seen in 6 infants (40 %) (Table 4) , either as an isolated finding (7 %) (Figure 2A ), or as a mixed pattern with areas of groundglass opacities (33 %), paraseptal emphysema (13 %) ( Figure 2B ), septal thickening (7 %), and non-septal thickening (7 %). A predominantly subpleural distribution was seen in 1 child (7 %); diffuse cysts with random distribution was seen in 4 cases (27 %) and upper lung zone predominance was seen in 1 case (7 %). follow-up HRCT scans (3 and 9 months and 4 and 9 months, respectively), and 1 patient had 3 follow-up HRCT scans (3, 6 and 12 months). Evaluation of the follow-up HRCT scans (Table   5 ) revealed the development of lung cysts in 5 patients (45 %) who had previously only had ground-glass opacities ( Figures 3A and 3B ). These new cystic changes were associated with a stable pattern of ground-glass opacities in 2 cases, decrease in the degree of ground-glass opacities in 1 case, and an aggravation of this pattern in 2 cases. These cysts were diffuse in all cases but showed a predilection for different regions of the lung: upper lobes (n=1), basal subpleural (n=1), peripheral (n=1), and central (n=1). In 1 case, lung cysts were homogenous and diffuse. Patients who had previously documented cysts on their initial HRCT scans also demonstrated change when follow-up HRCT was performed. In 5 patients (45 %), we noted an increase in the number or size of preexisting lung cysts ( Figures 4A and 4B ), which were associated with stable ground-glass opacities (n=4), aggravated ground-glass opacities (n=1), and progressive pulmonary fibrosis (n=1). The HRCT findings of pulmonary fibrosis consisted of bilateral and diffuse honeycombing, septal and non-septal thickening, and thickening of bronchovascular bundles and distortion of pulmonary fissures. In 1 patient, we observed persistent isolated ground-glass opacities.
Follow-up HRCT scan
Pathology findings
Eight of the 15 patients (53 %) underwent lung biopsy the median age at biopsy being 4
(range 3-7) months. Histological analysis revealed 2 main types of lesions. The first type occurred in the alveolar lumen, were we observed the following changes: accumulation of macrophages intermingled with few inflammatory cells and cholesterol cleft, type II pneumocyte hyperplasia, and alveolar septal thickening by primitive mesenchymal cells and lymphocytes either isolated or clustered ( Figure 5A ). These lesions were diffuse in 7 cases (90 Figure 6A ). There was no interstitial pulmonary fibrosis or alveolar proteinosis observed.
Relation between HRCT and pathology findings
Discussion:
With this report as our basis, the presence of bilateral ground-glass opacity or a combination of ground-glass opacities and cysts suggests the diagnosis of SFTPC mutation associated disorders and strongly encourage to perform genetic screening. We believe that this study is of value in highlighting this rare condition, and future prospective studies in children and adults are needed to further characterize CT findings in surfactant dysfunction disorders. Fig. 1 : Four-year-old boy with SFTPC mutation. HRCT section through the carina shows diffuse and uniform ground-glass opacities (A).Two-year-old girl with SFTPC mutation. Initial HRCT (at 3 months) shows homogenous ground-glass opacity in the lower lobes (B). One month old girl with compound heterozygous missense ABCA3 mutations. Initial HRCT shows ground-glass opacity in the lower lobes (C). Fig. 2 : Two-year-old girl with SFTPC mutation. Initial HRCT (at 16 months) shows paraseptal emphysema (curved arrow) associated with widespread cystic airspaces and diffuse ground-glass opacities (A). Seventeen-year-old boy with SFTPC mutation. The HRCT done at 14 -year -old showed isolated lung cysts with thin wall and variable sizes (B). One month old girl with compound heterozygous missense ABCA3 mutations. Initial HRCT shows association of ground-glass opacity, alveolar condensations and lung cysts (C). 
